verapamil has been researched along with cholecalciferol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Nitz, RE; Schraven, E; Trottnow, D | 1 |
| Fleckenstein-Grün, G; Frey, M; Matyas, S; Thimm, F | 1 |
| Czirfuzs, A; Fleckenstein-Grün, G; Frey, M; Matyas, S; Thimm, F | 1 |
| Chatelain, P; Feys, G; Laruel, A; Manning, AS; Mouton, J | 1 |
| Byon, YK; Fleckenstein, A; Fleckenstein-Grün, G; Frey, G; Gasser, R | 1 |
| Blanchard, J; Laird, HE; Pigman, EA | 1 |
| Kauppila, TJ; Kostiainen, R; Shrestha, B; Vaikkinen, A; Vertes, A | 1 |
8 other study(ies) available for verapamil and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of vitamin D3-induced vascular calcification by carbocromen.
Topics: Animals; Aorta; Calcium; Cholecalciferol; Chromonar; Coumarins; Magnesium; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Rats; Verapamil | 1983 |
Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
Topics: Animals; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cholecalciferol; Coronary Vessels; Lipids; Male; Rats; Rats, Sprague-Dawley; Verapamil | 1995 |
Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cells, Cultured; Cholecalciferol; Cholesterol; Coronary Vessels; Diltiazem; Disease Models, Animal; Humans; Hypertension; Middle Aged; Muscle, Smooth, Vascular; Nicotine; Nifedipine; Nitrendipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Risk Factors; Verapamil | 1994 |
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Calcinosis; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Cholecalciferol; Dose-Response Relationship, Drug; Indoles; Indolizines; Male; Mesenteric Arteries; Myocardium; Phenethylamines; Rats; Rats, Sprague-Dawley; Staining and Labeling; Sulfones; Verapamil | 1995 |
Diltiazem and verapamil prevent vitamin D3-induced myocardial calcium overload in rat papillary muscle: assessment with PVC ETH-123 calcium-selective microelectrodes.
Topics: Animals; Calcium; Calcium Channel Blockers; Cholecalciferol; Diltiazem; Microelectrodes; Papillary Muscles; Rats; Rats, Sprague-Dawley; Verapamil | 1996 |
A study of cadmium transport pathways using the Caco-2 cell model.
Topics: 2,4-Dinitrophenol; Biological Transport; Caco-2 Cells; Cadmium; Calcium; Cholecalciferol; Epithelial Cells; Epithelium; Ethylmaleimide; Humans; Intestinal Mucosa; Verapamil | 1997 |
Infrared laser ablation atmospheric pressure photoionization mass spectrometry.
Topics: Animals; Anisoles; Atmospheric Pressure; Brain; Cholecalciferol; Citrus; Dehydroepiandrosterone; Lasers; Mass Spectrometry; Plant Leaves; Rats; Toluene; Verapamil; Water | 2012 |